Indivior PLC (STU:2IVB)
€ 11.1 0.3 (2.78%) Market Cap: 1.41 Bil Enterprise Value: 1.37 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 61/100

Indivior PLC at Morgan Stanley Global Healthcare Conference Transcript

Sep 11, 2023 / 02:40PM GMT
Release Date Price: €20.85 (-1.88%)
Thibault Boutherin
Morgan Stanley, Research Division - Equity Analyst

Good morning, everyone. Thank you for joining this session as a Morgan Stanley Global Healthcare Conference. My name is Thibault Boutherin. I am part of the pharma equity research team based in London. Before we start, I just need to read some -- to refer to some important disclosures. Please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. And if you have any questions, please reach out to your Morgan Stanley (inaudible)

So for this session, I am delighted to have with me Mark Crossley, CEO of Indivior. And thank you very much for joining us today. So we will sharply start with the Q&A. But before that, Mark, do you want to maybe start with some [commentary] comments.

Mark Crossley
Indivior PLC - CEO & Executive Director

Certainly. And I'll layer on some disclosures with forward-looking statements that are available on indivior.com, if

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot